Blood eosinophil count in the general population: typical values and potential confounders

Sylvia Hartl, Marie-Kathrin Breyer, Otto C. Burghuber, Alina Ofenheimer, Andrea Schrott, Matthias H. Urban, Alvar Agusti, Michael Studnicka, Emiel F.M. Wouters, Robab Breyer-Kohansal

Source: Eur Respir J, 55 (5) 1901874; 10.1183/13993003.01874-2019
Journal Issue: May
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sylvia Hartl, Marie-Kathrin Breyer, Otto C. Burghuber, Alina Ofenheimer, Andrea Schrott, Matthias H. Urban, Alvar Agusti, Michael Studnicka, Emiel F.M. Wouters, Robab Breyer-Kohansal. Blood eosinophil count in the general population: typical values and potential confounders. Eur Respir J, 55 (5) 1901874; 10.1183/13993003.01874-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical variables and protein biomarkers associated with blood eosinophil count and asthma in young adults
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021


Budesoinde/formoterol: does eosinophil count cause different outcomes?
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019


The blood eosinophil count as a biomarker in COPD
Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD
Year: 2015



The search for the “healthy” blood eosinophil count
Source: Eur Respir J, 55 (5) 2000473; 10.1183/13993003.00473-2020
Year: 2020



LATE-BREAKING ABSTRACT: Additive role of exhaled NO and blood eosinophil count to predict wheezing in a random population sample
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

Clinical significance of blood neutrophil differential count in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017

Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis
Source: Eur Respir J, 59 (1) 2004590; 10.1183/13993003.04590-2020
Year: 2022



Impact of blood eosinophil variability in asthma: a real-life population study.
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021


Determinants of blood eosinophil count in adults from a large population-based study
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021


Low versus high Th2 asthma: variability of blood eosinophil counts in a longitudinal analysis
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA)
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020


Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease
Source: Eur Respir J 2016; 47:1299-1303
Year: 2016


Blood eosinophil counts and degree of allergen sensitization as age dependent correlations in children with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 452s
Year: 2001

Elevated baseline blood eosinophil count is related to greater lung function decline over 20-years of follow-up.
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019



Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD?
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019



Peripheral eosinophil count as a biomarker for the management of COPD: not there yet
Source: Eur Respir J, 50 (5) 1702165; 10.1183/13993003.02165-2017
Year: 2017



The reproducibility of COPD blood eosinophil counts
Source: Eur Respir J, 52 (1) 1800427; 10.1183/13993003.00427-2018
Year: 2018



Blood eosinophil count as a predictor of treatment response in adult patients with chronic cough
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Year: 2020


Lack of seasonal variability of blood eosinophil counts in COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

Blood eosinophil counts in COPD patients compared to controls
Source: Eur Respir J, 54 (4) 1900633; 10.1183/13993003.00633-2019
Year: 2019